For instance, upregulation of choline kinase (CHKA) can contribute to phosphocholine accumulation, a metabolic hallmark of aggressive breast tumors [150]; similarly, mutations or overexpressed isocitrate dehydrogenase (IDH) can produce oncometabolites that promote tumor progression [151]. This evidence concerns the gene IDH3A and breast neoplasm.